VCNX
Vaccinex, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website vaccinex.com
- Employees(FY) 38
- ISIN US9186403013
Performance
+2.4%
1W
+16.39%
1M
-46.6%
3M
-56.15%
6M
-40.48%
YTD
-93.23%
1Y
Profile
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.
Technical Analysis of VCNX 2024-05-10
Overview:
In analyzing the technical indicators for VCNX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
- 2024-05-15 18:52
VCNX Stock Earnings: Vaccinex Reported Results for Q1 2024(Investorplace)
- 2024-05-15 06:00
- 2024-04-02 01:52
VCNX Stock Earnings: Vaccinex Reported Results for Q4 2023(Investorplace)
- 2024-04-01 20:30
- 2024-03-26 20:30
- 2024-02-20 19:00
- 2024-02-14 19:00
Vaccinex, Inc. Announces Reverse Stock Split(Globenewswire)
- 2024-02-11 22:03
- 2024-02-06 19:00
Vaccinex Announces Pricing of $3.7 Million PIPE Financing(Globenewswire)
- 2023-12-03 19:00
- 2023-11-12 19:00
- 2023-10-30 21:00
- 2023-10-25 21:30
- 2023-10-05 20:08
Why Is Vaccinex (VCNX) Stock Up 26% Today?(Investorplace)
- 2023-09-28 09:00
Vaccinex Announces Pricing of $9.6 Million Public Offering(Globenewswire)
- 2023-09-27 20:00
- 2023-09-26 20:00
- 2023-09-25 20:00
- 2023-09-22 04:30
Vaccinex, Inc. Announces Reverse Stock Split(Yahoo Finance)
- 2023-08-13 20:10
- 2023-05-31 20:00
- 2023-05-15 04:45
- 2023-04-24 20:00
- 2023-04-11 20:00
- 2023-04-02 20:30
- 2023-04-02 20:00
- 2023-03-22 20:00
- 2023-03-20 20:30
- 2023-03-08 19:00
- 2023-01-26 05:06
The 3 Best Biotech Stocks Under $1 to Buy for January(Yahoo Finance)
Page 1 of 4
previousnext